EHR

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee 

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the…

1 year ago

Medusind Announces Strategic Affiliation with Tebra to Expand RCM Solutions and Practice Management Support for Independent Medical Practices

MIAMI, Nov. 19, 2024 /PRNewswire/ -- Medusind, a national leader in medical and dental revenue cycle management, announced today that it…

1 year ago

SIS Expands Capabilities with Strategic Acquisition of Surgical Notes

Enhancing Revenue Cycle Management (RCM) Services to Meet Growing Customer Demand ALPHARETTA, Ga., Nov. 19, 2024 /PRNewswire/ -- Surgical Information…

1 year ago

Lindus Health Rolls Out “All-in-One Infectious Disease CRO” Bespoke to Clinical Trials for Infectious Disease Interventions

NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life…

1 year ago

Northern Virginia Technology Council Recognizes DrFirst as a Top Tech Leader for Fifth Consecutive Year

2024 NVTC Tech100 Celebrates Innovative Companies Contributing to the Washington, D.C., Region's Economic Growth ROCKVILLE, Md., Nov. 19, 2024 /PRNewswire/…

1 year ago

WoundZoom Announces Launch of the WoundZoom LIGHT Mobile Application for Post Acute Care

BOCA RATON, FL / ACCESSWIRE / November 19, 2024 / WoundZoom is thrilled to introduce WoundZoom LIGHT, a HIPAA-compliant point-of-care…

1 year ago

Seen Health Emerges to Expand PACE Care to Rapidly Aging Senior Population

Company Has Raised $22 Million in Series A Funding to Enable Growth and Company's Culturally-Focused Centers, First to Soon Launch…

1 year ago

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Poster presentation highlighted results from confirmatory Phase 3 RESILIENT study of TNX-102 SL (sublingual cyclobenzaprine HCl) treatment demonstrating statistically significant…

1 year ago